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The focus of the British Society for Research on Ageing (BSRA) annual scientific meeting 2012 was aging
mechanisms and mitigants. The themes covered included epigenetics, stem cells and regeneration, aging pathways
and molecules, the aging bladder and bowel, as well as updates from the New Dynamics of Ageing (NDA)
programme. The topics incorporated new directions for staple aging research in caloric restriction (CR),
inflammation, immunesenescence, neurodegeneration, homeostasis and stress resistance, as well as newer research
areas such as bioengineering of tissues, including the internal anal sphincter and thymus.Introduction
The main focus of the meeting was aging mechanisms
and mitigants. The programme covered a number of
topics including epigenetics of aging, the aging bowel
and bladder, immunesenescence, and considered path-
ways and molecules involved in the aging process. This
meeting report aims to provide a general overview of the
topics discussed and the reader is referred to the cited
references to gain further insight into the meeting’s
content.Epigenetics and lifestyle influences on aging
Epidemiological studies from many of the well-established
longitudinal cohorts have indicated that 25% of an individ-
ual’s longevity is influenced by genetics, and the remainder
by environmental and lifestyle factors. This session focused
on epigenetics and its contribution to understanding the
mechanisms underlying lifestyle influences on longevity.
Epigenetics has many definitions; however, the concept of
genes and environmental stressors causing adaptations,
which determine our susceptibility to disease, is perhaps
most fitting when discussing aging and epigenetics.* Correspondence: hxg985@bham.ac.uk
MRC-ARUK Centre for Musculoskeletal Ageing Research, School of Immunity
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distribution, and reproduction in any mediumThe keynote address was given by Professor Osborne
Almeida (Max Planck Institute of Psychiatry, Munich,
Germany). Professor Almeida discussed the gene-
environment interactions which define and influence
brain and somatic aging, and in particular the role of
stress and metabolic modifiers. He introduced the con-
cept that genes account for large variations in human
lifespan and that it is as likely that extended lifespan is
due to the absence of harmful genes as the presence of
life-extending genes. In 1936, Hans Selye suggested that
stress is a major cause of disease and adaptation, and
that our ability to deal with the body’s responses to
stress defines the outcome of stress exposure. Professor
Almeida proposed the physiological response, in the
form of hyper-production of glucocorticoids (GC) via ac-
tivation of the hypothalamic-pituitary-adrenal (HPA)
axis, caused a number of cognitive impairments, for ex-
ample reduced memory in response to GC [1] which is
due to GC-induced damage. Indeed, stress-induced GC
production induces pathology similar to Alzheimer’s dis-
ease in the form of amyloid-β deposition [2]. His data
also suggests a link between stress and GC induction of
depression and dementia, which is cumulative with each
stressful event and therefore likely to have an epigenetic
basis. Memory has been shown to be linked with DNA
coding in neurons, and histone and DNA methylationed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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models of stress he showed that increased GC produc-
tion, depression and reduced learning were associated
with reduced DNA methylation at the arginine vasopres-
sin (AVP) locus, which causes increased upregulation of
AVP expression in the parvocellular subdivision of the
hypothalamic paraventricular nucleus and chronic hyper-
activity of the HPA axis [4]. Therefore, early life stressors
increase GC production via reduced methylation at the
AVP locus, which can ultimately increase responses to
stress in later life.
Professor Nektarios Tavernarakis (Institute of Molecular
Biology and Biotechnology, Heraklion, Greece) followed on
with a report on autophagy (cellular removal of damaged
proteins and organelles) and some of the life course
modulators of autophagy. Since the aging process is a
consequence of the accumulation of molecular damage, in-
creasing the risk of frailty and disease, autophagy is consid-
ered to play a role by removing damaged elements to
regain homeostasis. Professor Tavernarakis used caloric re-
striction (CR) to investigate the role of autophagy in lon-
gevity, and showed that both CR and reduced insulin
signaling increased Caenorhabditis elegans lifespan ap-
proximately two-fold. Combining the two resulted in a six
to seven-fold increase (equal to around 500 years in
humans). Reduced insulin/insulin-like growth factor (IGF)
signaling during CR led to increased autophagy and longev-
ity [5]. CR induces a decrease in mammalian target of
rapamycin (mTOR) signaling and an increase in sirtuin
activation. If autophagy is inhibited during CR then sirtuin
activation is reduced, supporting the role of sirtuins in
autophagy and CR-induced longevity [6].
Dr Werner Zwerschke (Cell Metabolism and Differen-
tiation Research Group, Austrian Academy of Sciences,
Innsbruck, Austria) developed these concepts further by
discussing the signaling crosstalk involved with CR-
induced longevity. He highlighted the cellular and bio-
chemical processes altered by reduced insulin/IGF and
mTOR signaling during CR, which are associated with
longevity, and these include: reduced protein translation,
increased detoxification pathways, increased autophagy
and increased resistance to oxidative stress [7]. Further-
more, Dr Zwerschke described how mutations, which
can reduce insulin/IGF and mTOR signaling, can influ-
ence morbidity and mortality in humans, particularly by
lowering pleiotropic actions on cells, and reducing risk
of developing cancers and cardiovascular disease [8].
Polymorphisms in IGF-1 receptor and FOXO3A are as-
sociated with increased lifespan and are more abundant
in centenarians, which may infer longevity through an
enhanced oxidative stress mechanism [9,10]. Import-
antly, these mutations and polymorphisms may be fur-
ther compounded by environmental conditions in early
life, since IGF-1 and growth hormone (GH) levels duringearly life are associated with increased lifespan [11]. A
key factor which may play a role in mediating this effect
is the accumulation of adipose tissue [12]. In particular,
white adipose tissue located viscerally around the major
organs is associated with increased insulin/IGF signaling
and reduced lifespan. Partial mechanisms underlying
these effects are revealed by fat-specific insulin receptor
knockout (FIRKO) mice, which are protected from
age-related loss of insulin sensitivity, diabetes and obes-
ity, and show altered production of the adipokines
adiponectin and leptin [13]. Adiponectin is negatively
correlated whilst leptin is positively correlated with body
fat and also associated with increased lifespan. Signaling
through the insulin/IGF axis is associated with longevity
and it is becoming clear that lifestyle can affect these
processes from an early age.
This session was concluded by Dr Gro Amdam
(School of Life Sciences, Arizona State University,
Tempe, AZ, USA) who presented data regarding the use
of the honey bee as a model of social interactions and
their effects on aging [14]. In the beehive there is a dis-
tinct social hierarchy, with clear roles and progression of
role adoption with age. All bees start as nurses, taking
care of the offspring and habitat before some progress to
foragers responsible for food collection. Interestingly,
the lifespan of nurses is around 50 days whilst the life-
span of foragers is around 7 days. Dr Amdam’s work
suggests this difference is due to social resource transfers
among bees, which implies a social environment effect
on aging. Nurse bees have reduced levels of lipofuscin, a
marker of oxidative damage, as well as increased learn-
ing capacity over forager bees. However, Dr Amdam
showed that if the social environment is altered by redu-
cing the number of nurses, then the foragers revert back
to being nurses and with this reverse their learning defi-
cits are overcome [15]. This plasticity is considered to
be mediated by a doubling of peroxiredoxins in the
brain upon role reversal in bees, which then slows
neuronal death.
Understanding how cellular aging impacts on function in
complex tissues: aging bowel and bladder
This session was a series of talks from researchers
funded by the Biotechnology and Biological Sciences Re-
search Council (BBSRC) initiative. The discussion aimed
to try and improve the understanding of the basis of
age-related decline in bladder and bowel function, and
loss of continence. Dr Tamas Ordog (Center for Individ-
ualized Medicine, Mayo Clinic, Rochester, MN, USA)
opened the session by discussing the impact of aging
and CR on the differentiation and function of interstitial
cells of Cajal (ICC) in the gut. ICC are mesodermal elec-
trical pacemakers and neuromodulators responsible for
regulating basal rhythm leading to contraction. Loss of
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timately reduced nutrient intake via early satiation [16].
Furthermore, there is a linear age-related ICC decline
equating to around 1% per year [17]. The Klotho knock-
out mouse manifests a premature aging phenotype and
was shown to have reduced food intake, reduced neuro-
transmission and reduced gastric compliance but not
emptying. Dr Ordog’s group has shown that the Klotho
mouse has reduced numbers of ICC suggesting an age-
dependent loss of ICC [18]. In protein-energy malnutrition
there is also a reduced number of ICC, further augmenting
ICC association with nutrient-sensing mechanisms. These
data suggest that aging associated with gastric dysfunction
mimics CR in reducing food intake and could potentially
represent one aspect of the CR pro-longevity mechanism.
Dr Mark Yeoman (School of Pharmacy and Biomolec-
ular Sciences, University of Brighton, Brighton, UK)
discussed the impact of gastrointestinal (GI) disorders
on older adults and the problems associated with
understanding the mechanisms involved. Fecal output is
negatively affected by age and the percentage of compac-
tion increases causing decreased colonic motility. These
changes are suggested to be a result of reduced mucosal
serotonin availability and a subsequent reduction in
mucosal serotonin transporter (SERT) expression, which
has been shown in aging [19]. Serotonin is the neuro-
transmitter responsible for nutrition absorption and
motility in the GI tract. Found primarily in the entero-
chromaffin (EC) cells, serotonin allows communication
between the gut lumen and neurons. Dr Yeoman
suggested that aging is also associated with reduced
amplitude and frequency of electrical signaling within
colonic migrating motor complexes (CMMC), respon-
sible for propelling fecal content along the large bowel.
Additionally, he proposed that there is also an age-
related loss of tachykinin NK2 mediated signaling in the
GI with age, which would in turn affect the signaling of
CMMC. Thus selective NK2 receptor antagonists can
potentially reactivate inhibited motility in older adults.
Professor David Grundy (Department of Biomedical
Science, University of Sheffield, Sheffield, UK) presented
data examining GI sensory function of young and old
mice. He showed that changes in the enteric nervous
system with age results in increased incidence of consti-
pation, rectal sensitivity and evacuation. This also ap-
pears to be related to dysfunction of the nervous system,
as evident by older individuals with reduced rectal sensi-
tivity and compliance. In this study, rectal distension
caused increased jejunal mesenteric afferent discharge in
both ages, but had reduced low threshold (LT) and high
threshold (HT) neuron activity. Professor Grundy sug-
gested that age attenuated all three subtypes of afferent
neurons and reduced neuronal signaling, which may be a
result of reduced serotonin signaling.Dr Sarah Rayment (Queens Medical Centre, University of
Nottingham, Nottingham, UK) followed on by discussing
the potential use of drugs not normally associated with
fecal incontinence (FI). Currently, around 10% of commu-
nity dwelling older adults and 50% of nursing home resi-
dents suffer from FI; however, very few therapeutic
interventions are available. Dr Rayment’s previous work
in sheep showed that α1-adrenoreceptor agonists,
normally used for hypotensive patients, caused vaso-
constriction in the sphincter and increased pressure in
the bowel [20]. Furthermore, α2-adrenoreceptor ago-
nists such as clonidine, normally used in hypertensive
patients and for attention deficit-hyperactivity disorder
(ADHD), appear to modify compliance and sensitivity
of the sphincter.
Professor Alison Gurney (Faculty of Life Sciences,
Manchester University, Manchester, UK) opened the
second session on bowel dysfunction by discussing the
role of potassium and calcium channels in smooth
muscle function. Normal bladder contractions are
dependent on increased Ca2+ release in the smooth
muscle, and Ca2+ release can be generated in ‘sparks’
and ‘waves’ [21]. Smooth muscle contains K+ channels
which set the resting membrane potential, and detect
and respond to a rise in intracellular Ca2+. Loss of K+
channels results in bowel tissue dysfunction, for example
mice which lack the large-conductance Ca2+ activated
K+ channel (BKCa) present with incontinence and an
overactive bladder [22]. A lack of BKCa was shown to re-
duce spontaneous outward current even though Ca2+
concentrations in the bladder smooth muscle remained
unchanged. With age there is an altered concentration
of cyclic nucleotide phosphodiesterases (PDEs) and
PDE-5 is known to relax muscle via a nitric oxide (NO)
mechanism. Inhibition of PDE-5 increases cAMP and
cGMP which act on BKCa, allowing increased bladder
control and relaxation. Furthermore, mice lacking BKCa
and PKG1, activated upon binding with cGMP, do not
have increased muscle relaxation [23]. Finally, drugs like
sildenafil, which raise intracellular cGMP concentra-
tions, promote BKCa activity and ultimately smooth
bladder muscle relaxation, may have utility in older
adults to improve continence.
Professor Christopher Fry (Institute of Biosciences and
Medicine, University of Surrey, Surrey, UK) supplemented
the earlier talk by Dr Rayment by discussing the sensory
functions of the bladder in response to aging. An overactive
bladder (OAB) is associated with increasing age, and can be
characterized by symptoms of urgency, frequency and
nocturia. OAB is a sensory and neural processing dysfunc-
tion rather than a motor disorder, since there is no age dif-
ference in bladder contractions. The normal function of the
bladder involves release of the neurotransmitters acetylcho-
line (ACh), ATP and NO, which activate local afferent
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(CNS), or to perform functional contraction of the detrusor
muscle. Furthermore, distension causes increased ATP re-
lease from the bladder epithelial cells and exerts its actions
specifically through P2X3 ATP sensory receptor activation
on the afferent nerve plexus. In older adults there is an in-
creased release of ACh and ATP during distension-induced
release leading to sensory dysfunction and OAB disorders
[24]. Professor Fry suggested that further understanding of
the sensory mechanisms attributed to OAB disorders will
allow successful targets to be determined. Currently,
therapeutic use of compounds such as oxybutynin, an
antimuscarinic (ACh antagonist) used to treat intractable
detrusor muscle overactivity, and vanilloids (capsaicin,
resiniferatoxin) to attain bladder deafferentation, need
further investigation to fully discern their actions.
Professor Khalil Bitar (Wake Forest Institute for Re-
generative Medicine, Winston-Salem, NC, USA) ended
the day with a fascinating description of how to poten-
tially solve age-associated bowel and bladder dysfunction
by bioengineering an internal anal sphincter (IAS).
Within 5 days of culture, alignment of smooth muscle
sheets was complete and the engineered IAS was both
functional and produced force. Cells from enteric
neurospheres were then co-cultured with IAS smooth
cells using dual-layered hydrogels which permitted cir-
cular construct formation. This construct contracted in
response to ACh and relaxed in response to cAMP, be-
fore implantation onto the back of an athymic (Rag1−/−)
rat and neovascularized. The construct was morpho-
logically good and responded to ACh stimulation. Fol-
lowing this the innervated human IAS construct was
implanted in situ into the rodent. Neural networking
and GI motility was restored using autologous cell
sources and electrical field stimulation suggested func-
tional capabilities [25]. Defecation was normal, further
suggesting full functional capacity. These data represent
the potential for overcoming GI problems in humans by
replacing affected areas with bioengineered fully func-
tional and intrinsically innervated human IAS tissue.
New Dynamics of Ageing
The New Dynamics of Ageing (NDA) programme (www.
newdynamics.group.shef.ac.uk) is a research initiative
funded through a joint collaboration between five UK
Research Councils. It supports multidisciplinary research
to elucidate the forces driving the aging process and ul-
timately aims to develop methods and protocols to im-
prove the quality of life of older adults. Three of the
biogerontological researchers funded by the NDA
presented their findings.
Dr Terence Davis (Institute of Cancer & Genetics, Cardiff
University, Cardiff, UK) uses Werner syndrome (WS) fibro-
blasts to investigate cellular aging via modulation of thep38 stress-signaling pathway. Activity of this pathway has
been shown to be augmented in WS forcing arrest of the
cell cycle and subsequent senescence. Using p38 specific in-
hibitors, the team was able to investigate the exclusive ac-
tion of p38 demonstrating a partial normalization of the
growth of WS fibroblasts and confirming a role for p38 in
the development of senescence [26]. However, in vivo effi-
cacy and tolerance of these compounds are limited, with
side effects including CNS inflammation and liver toxicity
when tested in both mice and dogs. Consequently, the need
for new targets and compounds with fewer side effects are
required. Dr Davis and colleagues have been able to
synthesize three new inhibitors specific for the major down-
stream target of p38, MK2. This is the major kinase respon-
sible for phosphorylation of HSP27, the main driver behind
F-actin stress-fiber formation which features prominently
in young WS fibroblasts. Preliminary data suggest that in-
hibition of MK2 is able to marginally increase the growth
potential of WS fibroblasts.
Dr Penelope Mason (Department of Biochemistry,
University of Oxford, Oxford, UK) also uses WS as a model
system and has created a plasmid containing miRNA
targeted against the Werner protein (WRN), addition of
which results in the reversible knockdown of WRN helicase
and exonuclease in cells aged in culture [27]. The presence
of WRN is thought to prevent premature aging by stabiliz-
ing the genome. Through utilization of this new system, Dr
Mason aims to assess the role of DNA damage in the in-
duction of senescence and its ability to drive the aging
process. Additionally, she also presented work on the
cellular alterations that take place during replicative senes-
cence. Fibroblasts treated with rapamycin, an inhibitor of
mammalian target of rapamycin complex 1 (mTORC1),
exhibited a reduced growth rate and underwent a greater
number of population doublings before becoming senes-
cent. Dr Mason was able to show a significant down-
regulation of proteins involved in the regulation of genome
structure and stability upon inhibition of mTORC1. This il-
lustrates a novel pathway in the development of replicative
senescence.
To conclude the session, Niharika Arora Duggal
(Medawar Centre for Healthy Ageing Research, University
of Birmingham, Birmingham, UK) presented her
work on the synergistic effects of emotional and
physical stress on immunesenescence, and hypothe-
sized that the synergistic effects of both stressors act
to accelerate immunesenescence in older adults. Hip
fracture is a common event in older adults and a
major risk factor for progression to ill health and
frailty. There are over 80,000 hip fractures each year
in the UK alone with a 1-year mortality of 25%. In
addition to this, one third of older adult patients
with hip fractures go on to develop depression,
which may further confound their ability to fully
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strated a reduction in both neutrophil superoxide
production and natural killer (NK)-cell cytotoxicity
in patients who suffered hip fracture and then went
on to develop depression, whereas those with hip
fracture alone did not show suppressed immunity.
Thus treating depression in these patients may rep-
resent an effective route to improving outcomes after
falls and hip fractures.
Aging, regeneration and stem cells
Professor Valery Krizhanovsky (Weizmann Institute of
Science, Rehovot, Israel) presented his work on the abil-
ity of senescent cells to limit tissue damage response. In
the presence of an intact senescent machinery (INK4a,
p53 and p21 pathways), the level of liver fibrosis is re-
stricted; however, induction of senescence by knock-
down of p53 and/or INK4a in hepatic stellate cells
subsequently increases the levels of hepatic fibrosis.
Using a model in which senescence has been disabled by
knockdown of p53, Professor Krizhanovsky and col-
leagues demonstrated the ability of NK cells to recognize
and subsequently clear senescent hepatic stellate cells.
This is achieved through ligation of the NK cell receptor
NKG2D with its ligands MICA and ULBP2 expression
of which is up-regulated on the surface of senescent
cells. The perforin and granzyme pathway then mediates
killing of bound senescent cells, and their subsequent
degradation and removal. Upon senescence, cells also
up-regulate expression of decoy receptor 2 (DcR2), a
molecule that inhibits the death receptor pathway by
blocking TRAIL-R [28]. This protects senescent cells
from NK cell killing mediated by the death receptor
pathway, and instead restricts NK cell mediated killing
to the perforin and granzyme pathway. Ultimately, a
buildup of senescent cells with age may be the result of
impaired immune surveillance and therefore decreased
clearance of these cells.
Professor Janet M Lord (MRC-ARUK Centre for Mus-
culoskeletal Ageing Research, University of Birmingham,
Birmingham, UK) continued the immunity theme, and
described her research of the decline of the innate [29]
and adaptive immune systems. On the innate side, Pro-
fessor Lord described how, with aging, NK cell numbers
increase but their cytotoxic ability decreases. This
decrease is due to reduced perforin release at the im-
mune synapse, the contact point between the NK cell
and its target, due to a lack of localization of perforin
secretory granules to the synapse [30]. Together with
Professor Krizhanovsky's findings, these data may help
to explain why senescent cells accumulate with age. She
also discussed the possible causes of the age-related in-
crease in inflammatory cytokines, so-called inflammaging,
[31] how lifestyle factors are key drivers of thisphenomenon and latent cytomegalovirus (CMV) infection
can be ruled out as a causative agent [32].
Although the negative effects of advancing age on T
cell development have been widely reported in literature,
it remains unclear as to whether these effects are due to
changes in the thymic microenvironment, a reduction in
the number of stem cells feeding the thymus or the pres-
ence of intrinsic defects within the stem cell compart-
ment itself. To address this, Professor Richard Aspinall
(Translational Medicine, Cranfield University, Cranfield,
UK) developed a model system using both human kera-
tinocyte and fibroblast cell lines grown on a synthetic
matrix, which allow the deconstruction of the thymic
microenvironment. By seeding CD34+ stem cells isolated
from cord blood onto the meshed thymus, he was able
to demonstrate the development of immature (CD4+ or
CD8+) and mature (CD4+ or CD8+) thymocytes. How-
ever, when stem cells from old blood were seeded into
the meshed thymus, there was a distinct lack of T cell
development occurring suggesting an intrinsic defect in
the stem cells isolated from old blood.
Dr Helen A Thomason (Manchester Immunology
Group, University of Manchester, Manchester, UK)
presented her work on the role of protein kinase C alpha
(PKCα) in the regulation of desmosomes and wound
healing [33]. Desmosomes are adhesion complexes
found in the cell membrane, which mediate cell-to-cell
adhesion and maintain the integrity of the epithelium.
Upon wounding these complexes switch from a Ca2+-
independent ‘super-adhesive’ state to a Ca2+-dependent
non-adhesive state, allowing keratinocyte migration and
subsequent re-epithelialization. Older adults have an in-
creased susceptibility to development of chronic wounds
with 5% developing leg ulcers which, if left untreated,
can become chronic. Dr Thomason and colleagues
showed that expression of genes encoding desmosomal
proteins was decreased in older adults with desmosomes
remaining in a Ca2+-independent, ‘hyper-adhesive’ state.
This prevents keratinocyte migration and results in de-
layed wound-healing. PKCα regulates the switch be-
tween the Ca2+-independent and Ca2+-dependent states,
and in chronic, non-healing wounds of older adults,
PKCα failed to co-localize with the membrane bound
desmosome preventing the switch to a Ca2+-dependent
state, thus preventing wound healing. A mouse model
expressing a constitutively active form of PKCα showed
an increased rate of re-epithelialization and faster wound
healing.
To conclude the session, Song Baik (School of
Immunity and Infection, University of Birmingham,
Birmingham, UK) presented her work on the reversal of
thymic atrophy. Using inducible pluripotent stem (iPS) cells
produced from somatic cells and re-programming them
back to pluripotency, she was able to produce a fully
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blastocyst of a nude mouse, Ms Baik and colleagues
were able to ‘grow’ a thymus, with the correct thymic
architecture in an otherwise athymic mouse. In addition,
the iPS thymus was fully functional containing all four T
cell developmental subsets, and produced T cells that
were able to migrate into secondary lymphoid tissue and
respond to activation. The potential of iPS cells to be
used to combat thymic atrophy in older adults by regen-
erating an older thymus is therefore an interesting and
realistic concept.
Pathways, molecules and interventions
The final session of the meeting considered ways to
intervene in improving lifespan. Professor Gordon
Lithgow (Buck Institute for Research on Aging, Novato,
CA, USA) presented a role for genes and small mole-
cules in enhancing lifespan, as well as being potential
pharmaceutical targets. Professor Lithgow suggested that
maintenance of protein homeostasis was a key mediator
in lifespan extension. Increased expression of protein
chaperones and heat shock proteins are associated with
longevity, whereas aging is associated with a loss of pro-
tein homeostasis and an accumulation of insoluble pro-
tein aggregates. Professor Lithgow chose the relationship
between normal aging and neurodegenerative disorders
to assert his point. Neurodegenerative pathologies such
as Alzheimer’s disease and Parkinson’s disease have an
accumulation of insoluble protein aggregates which con-
tribute to disease severity. Normal aging also involves in-
creased production of protein aggregates and he
demonstrated that reduction of aggregates in nematodes
significantly increases lifespan [34]. Screening for small
molecules in the Lithgow Lab, which may retard the
aging process, revealed some interesting candidates: ex-
posure to Thioflavin T (ThT), curcumin and rifampicin
block early protein aggregation, reduce pathology and
increase lifespan in C Elegans [35]. The mechanism of
ThT actions appear to be dependent on a protein
homeostasis network regulated by heat shock factor 1
(HSF-1), transcription factor SKN-1 and autophagy.
Finally, Professor Lithgow described the role of metal
homeostasis (metallostasis), and the link between in-
creased metals such as aluminum and neurologic disease
and protein aggregation. He suggested that aluminum
accumulation alters the composition of other metals and
reduces lifespan [36].
Investigating a second mechanism for lifespan exten-
sion, Dr Colin Selman (School of Biological Sciences,
University of Aberdeen, Aberdeen, UK) presented
work on insulin/IGF-1 signaling (IIS) and its effects on
cellular stress resistance. Reductions in IIS increase
lifespan via reduction in insulin receptor substrate 1
(IRS1) levels [37]. Previous work has demonstratedthat this lifespan extension is not due to alterations in
anti-oxidant protection, reduced oxidative damage or
enhanced base excision repair. Examination of the ef-
fects of oxidative and non-oxidative stressors via ex-
posure to hydrogen peroxide, cadmium and methyl
methanesulfonate on the survival of fibroblasts isolated
from IRS1 null mice revealed no differences. Instead
Dr Selman agreed with the proposals of Professor
Lithgow, that there was a link between cellular stress
resistance and protein aggregation. In particular, he
suggested a role for endoplasmic reticulum stress in
disrupting protein folding homeostasis, contributing to
age-related pathology and that the IRS1−/− mice were
more resistant to this stress.
Disuse atrophy is commonly seen in the older adult
population as a result of age-related inactivity. In a num-
ber of conditions, angiotensin II type I receptor blocker
(ARB), losartan, has produced beneficial effects in ameli-
orating muscle atrophy. However, these effects seem to
be age-dependent, as shown by Tyesha Burks (School of
Medicine, Johns Hopkins University, Baltimore, MD,
USA). In young mice, losartan was unable to protect
from disuse atrophy and only conferred partial protec-
tion in adult mice, but was able to completely protect
against the loss of muscle mass in older mice [38]. In
older mice, losartan prevents angiotensin II from bind-
ing to angiotensin receptor 1 (ART1), thereby modulat-
ing activity of the transforming growth factor-β signaling
pathway known to be downstream of ART1. In addition,
losartan appears to be able to modulate the Akt/mTOR/
FOXO3A pathway in an age-dependent manner, a path-
way already known to be involved in the loss of muscle
mass due to physical inactivity.
To conclude the annual scientific meeting, Professor
Richard Faragher (School of Pharmacy and Bimolecular
Sciences, University of Brighton, Brighton, UK) gave a
short talk on the relationship between resveratrol and
replicative senescence. Aging can be modulated by envir-
onmental factors including CR and single gene muta-
tions such as daf2, Chico and Igfr1. The promise of
aging research is to mimic these environmental factors
and the use of resveratrol has been widely proposed as a
CR mimetic by acting through sirtuin1 (SIRT1). How-
ever, its precise mode of action in relation to lifespan
extension remains unclear, although its anti-cancer ac-
tivity is thought to contribute. Professor Faragher and
colleagues reported that exposure of fibroblasts to res-
veratrol induces reduced proliferation and p38 MAPK-
dependent senescence in vitro. However, circulating
levels of resveratrol achieved in supplementation studies
remain too low to be able to induce replicative senes-
cence. Professor Faragher concluded that resveratrol
altering cellular turnover as the mechanism of anti-aging
effects is unfounded [39].
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